Concept to Clinic: CDK 4/6 Inhibition in ER-Positive Breast Cancer
Recent data indicate a role for a pathway involved in controlling cell proliferation as a potential site for therapeutic intervention in breast cancer.
Extensive Lung-MAP Trial to Study 5 Novel Drugs
Five novel agents for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung will be evaluated in the recently launched Lung-MAP trial.
